Wells Fargo & Company Teva Pharmaceutical Industries LTD Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Wells Fargo & Company holds 925,219 shares of TEVA stock, worth $15.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
925,219
Previous 291,560
217.33%
Holding current value
$15.8 Million
Previous $3.04 Million
328.98%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TEVA
# of Institutions
556Shares Held
546MCall Options Held
19.8MPut Options Held
14M-
Black Rock Inc. New York, NY43.7MShares$747 Million0.01% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.6MShares$660 Million36.28% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L334.6MShares$591 Million7.05% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.9MShares$511 Million6.74% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L328.8MShares$492 Million4.57% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...